Both are pharmacologically active compounds with documented effects on the cardiovascular system, the gastrointestinal tract, and metabolic regulation
Retatrutide is an investigational peptide being studied for its potential role in metabolic and weight management within controlled research settings under medical supervision
Protein ice cream is already in the freezer
This litigation centers on serious claims against pharmaceutical giants Novo Nordisk and Eli Lilly and Co., alleging that they failed to adequately warn users about potential severe digestive side effects associated with these GLP-1 class drugs, which are commonly prescribed for diabetes management and weight loss
These alternatives are designed to provide sustainable, long-term results whilst minimising health risks
doi: 10.1016/S2213-8587(24)00271-7 [DOI] [PubMed] [Google Scholar] 34.Marx N, Husain M, Lehrke M, Verma S, Sattar N